Abequolixron

Generic Name: Abequolixron

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₄H_₃₃ClF_₃NO_₃

CAS Number: 610318-54-2

Unique Ingredient Identifier: Q26B92650V

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Abequolixron/Docetaxel Produces Durable Responses in Recurrent Advanced NSCLC

Abequolixron (RGX-104) plus docetaxel showed promising efficacy (ORR 38%, median DOR 5.8 months) and was well-tolerated in advanced/metastatic nonsquamous NSCLC patients. A phase 2 randomized trial is planned to further evaluate this combination vs docetaxel alone.

Related Clinical Trials:

A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy